ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

BLCO Bausch plus Lomb Corporation

13,26
-0,60 (-4,33%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Bausch plus Lomb Corporation BLCO NYSE Common Stock
  Änderung Änderung % Aktuell Zeit
-0,60 -4,33% 13,26 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
14,04 13,53 14,35 13,60 13,86
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.5.202412:58BWBausch + Lomb Announces First-Quarter 2024 Results
29.4.202413:00BWBausch + Lomb Announces Presentation of New Data at the..
25.4.202414:30BWBausch + Lomb Announces Statistically Significant Results..
18.4.202413:00BWBausch + Lomb Reports More Than 84 Million Units of Contact..
15.4.202418:00BWBausch + Lomb Will Release First-Quarter 2024 Financial..
27.3.202412:00BWBausch + Lomb Will Present New Scientific Data and Analyses..
04.3.202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202414:12EDGAR2Form 8-K - Current report
28.2.202414:00BWBausch + Lomb Announces Appointment of Karen L. Ling to..
21.2.202413:00EDGAR2Form 8-K - Current report
21.2.202413:00GLOBEEmergent BioSolutions Appoints Industry Leader Joseph C...
21.2.202412:58BWBausch + Lomb Announces Fourth-Quarter and Full-Year 2023..
05.2.202418:00BWBausch + Lomb Will Release Fourth-Quarter and Full-Year 2023..
08.1.202412:59BWBausch + Lomb Receives FDA Approval for TENEO™ Excimer Laser..
03.1.202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202415:00BWBausch + Lomb to Participate in the 42nd Annual J.P. Morgan..
15.11.202312:59BWBausch + Lomb Reports More Than 76 Million Units of Contact..
13.11.202322:47EDGAR2Form 8-K/A - Current report: [Amend]
07.11.202323:00EDGAR2Form 8-K/A - Current report: [Amend]
01.11.202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01.11.202312:02EDGAR2Form 8-K - Current report
01.11.202311:58BWBausch + Lomb Announces Third-Quarter 2023 Results and..
26.10.202312:59BWBausch + Lomb Will Present New Scientific Data and Analyses..
16.10.202318:00BWBausch + Lomb Will Release Third-Quarter 2023 Financial..
04.10.202312:59BWBausch + Lomb Will Present New Scientific Data and Analyses..
03.10.202323:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.9.202322:24EDGAR2Form 8-K - Current report
29.9.202316:00BWBausch + Lomb Completes Acquisition of XIIDRA®
26.9.202312:59BWBausch + Lomb Launches LUMIFY EYE ILLUMINATIONS™ in the..
20.9.202312:59BWBausch + Lomb’s ONE by ONE and Biotrue® Eye Care Recycling..
14.9.202323:26EDGAR2Form 8-K - Current report
14.9.202323:25BWBausch + Lomb Announces Pricing of Senior Secured Notes..
12.9.202312:59BWBausch + Lomb Launches MIEBO™ (Perfluorohexyloctane..
11.9.202313:22EDGAR2Form 8-K - Current report
11.9.202313:07BWBausch + Lomb Announces Launch of Proposed Financing for..
06.9.202323:58BWBausch + Lomb Announces Disclosure of Historical and Pro..
06.9.202323:28EDGAR2Form 8-K - Current report
06.9.202312:59BWBausch + Lomb Will Present New Scientific Data on its..
29.8.202323:05EDGAR2Form 8-K/A - Current report: [Amend]
29.8.202313:00BWBausch + Lomb Will Participate at the 2023 Wells Fargo..
24.8.202313:00BWBausch + Lomb Announces Expiration of Hart-Scott-Rodino..
02.8.202323:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
02.8.202323:09EDGAR2Form S-3ASR - Automatic shelf registration statement of..
02.8.202322:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Kürzlich von Ihnen besucht

Delayed Upgrade Clock